Filter By Unselect All

Sub Category Unselect

Country Unselect See All

Companies Unselect See All

Selected Filter(s): Reset All

  • Category
  • Reset
  • Sub Category
  • Reset
  • Country
  • Reset

Contact

Extractables & Leachables for Pharma & Biotech

Analytical >> Extractables and Leachables >> Testing Services

AMRI offers a complete suite of extractables and leachables (E&L) testing services to assist in the evaluation of the manufacturing process

Contact

Leachables & Extractables Studies

Analytical >> Extractables and Leachables >> Testing Services

Analytical research and development (AR&D) offers standalone services and supports our formulation development activities.

Contact

Extractable & Leachable Study

Analytical >> Extractables and Leachables >> Testing Services

Crenza is a full scale R&D centre for development of Parenteral and Ophthalmic drug products. Crenza is founded by Industry professionals with invaluable experience and proven track record of development and commercialization of Parenteral and Ophthalmic drug products for regulated markets.

Contact

Assessment of Leachables & Extractables In Drug Products

Analytical >> Extractables and Leachables >> Testing Services

Our extractables and leachables analytical services include: Modify and validate controlled extractable methods for testing and profiling of leachables and Develop HPLC, GC, and MS methods for controlled extractables from pharmaceutical containers, closures and devices.

Contact

Assessment of Leachables & Extractables In Drug Products

Analytical >> Extractables and Leachables >> Testing Services

Our scientists conduct extractables and leachables studies in accordance with Good Manufacturing Practices (GMPs) ,PQRI recommendations, United States Pharmacopeia (USP) requirements.

Contact

Assessment of Leachables & Extractables In Drug Products

Analytical >> Extractables and Leachables >> Testing Services

Primera specializes in customized analytical method development, transfer and validation using state-of-the-art analytical tools. We also provide cGMP Sample Storage and testing services. With no observations and no 483 findings from two FDA audits, We are in full compliance with GLP/cGMP regulations.

Contact

Extractable & Leachables

Analytical >> Extractables and Leachables >> Testing Services

Extractable and Leachables (both organic and inorganic) study in drug product. It offers development and validation of analytical methods, study stability sample for establishment of leachables maximum level, and qualification of extractable and leachables.

Contact

Leachable Method Development, Validation & Monitoring

Analytical >> Extractables and Leachables >> Testing Services

From residual solvents and process-related impurities to extractables/leachables and degradant-related impurities, Eurofins BioPharma Product Testing offers a broad range of services in support of impurities testing.

Contact

Extractable & Leachable Studies

Analytical >> Extractables and Leachables >> Testing Services

Our integrated product development services help biopharmaceutical companies shorten time to market, manage risk and access new global markets to maximize portfolio value.

Contact

Extractables & Leachables Study

Analytical >> Extractables and Leachables >> Testing Services

GRAM Laboratories offers development of a clinically relevant and more stable formulation. This is made possible because of the knowledge gained from preformulation evaluation. Formulation studies are customized to achieve the most appropriate formulation in a timely and cost efficient manner.

The examination of extractable and leachable substances (such as plasticizers, antioxidants, stabilizers and dyes) is extremely important for the protection of patients and for regulatory documentation destined for authorities such as the FDA and EMA. In recent years, the pharmaceutical industry has developed a better understanding of the impact of extractables and leachables on patient safety and drug product interaction, leading to increased scrutiny by the regulators. When there is a change in a drug product’s immediate packaging materials, there is a regulatory requirement to assess the impact of the change. Testing is conducted to ensure that the materials are not leaching into a pharmaceutical or from a medical device to a patient. Typically, the testing is done on rubber and polymer materials or components used in medical device and pharmaceutical packaging. Analytical Testing Service providers offers a number of services for Extractables and Leachables such as: Test strategy planning and data evaluation based on the available information; Supporting of risk analysis procedures; Development of a tailored study design for extractables and leachables or chemical characterization, according pharmaceutical standards and ISO 10993 part 12/18; Extractables profiling (inorganic and organic extractables); Sequential extractions and alternative extraction techniques for isolating extractables in materials made from polymers, metals and ceramics; Characterization of extractables by chromatographic and spectroscopic investigations; Identification of a material and the identification and quantitation of the chemicals present in materials by chemical characterization; Identification and evaluation of the physico-chemical, mechanical, morphological and topographical properties of materials; Chemical and structural changes (e.g. by DSC) on polymeric materials after stressing by temperature or irradiation; Determination of the Analytical Evaluation Threshold (AET); Calculation of the AET based on Safety Concern Threshold (SCT) or Threshold of Toxicological Concern (TTC) and ICH M7 guideline; Biocompatibility: USP<87> and USP <88>; Toxicological assessments and method development and validation of potential leachables in pharmaceutical products and from medical devices; Performing leachables studies or simulated use studies on pharmaceutical products and medical devices; Reporting and evaluation of results within the current guidelines. Extractable and Leachable testing also is expanding in the extent and complexity of testing, which requires comprehensive design of the E&L program based on sound scientific principles. Trending from just detecting and quantifying the known and expected leachables has transitioned to now addressing the issues of unknown and unexpected leachables. The complexity of the E&L study program poses significant challenges for pharmaceutical product development, and requires significant expertise for the successful design and execution of an E&L program.

ABOUT
THE PAGE

COLLAPSE

PharmaCompass >>